Success is in the Air for Lou Bock
September 28th, 2009 |
Jennifer Jones

It’s August 2009 and in the last 12 months, Lou Bock‘s portfolio has had some impressive success. He talks about how Zogenix, Horizon Therapeutics, Somaxon, Prestwick Pharmaceuticals and Orexigen have all done well. The Scale Venture Partners Managing Director has seen two positive Phase III outcomes, 2 FDA approvals and one progressing to approval since August 2008.
Posted in:
Audio Podcast, Healthcare, Venture Perspectives by Scale Venture Partners